Fresenius stock: FMC sale raises EUR 524 million for growth
Published on 11/14/2026 at 11:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSFresenius frees capital through FMC sale
- The healthcare group reduced its financial investment in Fresenius Medical Care to approximately 20 percent.
- Settlement is expected on November 16, while a 90-day lock-up applies to the remaining holding.
- The anticipated book gain will be recognized as a special item in fourth-quarter 2026 results.
On Thursday, November 12, Fresenius completed the sale of 13.4 million shares in Fresenius Medical Care at a placing price of 39.00 euros per share. The healthcare group said the transaction generated gross proceeds of approximately 524 million euros and reduced its financial investment in FMC to approximately 20 percent. The details were released by Fresenius.
Sale supports growth investment
Fresenius said the net proceeds will be available for its growth platforms and align with the capital allocation priorities of its FutureFresenius strategy. Settlement is expected on Monday, November 16. The remaining FMC shares are subject to a 90-day lock-up, subject to customary exceptions.
The company expects a book gain in the low- to mid-double-digit million euro range to appear in fourth-quarter 2026 results as a special item. The transaction was carried out through an accelerated bookbuild for institutional investors.
Shares finish week higher
Fresenius stock traded at 53.68 euros on Lang & Schwarz at 11:51 CET on Saturday, November 14, 0.11 percent above the Xetra close of Friday, November 13. On Xetra, the shares gained 2.17 percent during the week from the November 6 close to the November 13 close.
Fresenius company facts
- Company: Fresenius SE & Co. KGaA
- ISIN: DE000FRE5EN2
- WKN: FRE5EN
- Ticker: FRE
- Home exchange: Frankfurt Stock Exchange and Xetra
- Lang & Schwarz quote: 53.68 euros on November 14, 2026, at 11:51 CET
- Xetra close: 53.62 euros on November 13, 2026
- Weekly performance: 2.17 percent from the November 6, 2026 close of 52.48 euros to the November 13, 2026 close
- Index: DAX 40
Fresenius is a DAX 40 member, linking its shares to the broader German blue-chip market through the DAX 40.
For more company-specific developments, see More news and analyses on Fresenius stock.
